FYERS
Brawn Biotech21.49
-0.01 (-0.05%)

Brawn Biotech Share Price

21.49-0.01 (-0.05%)
+4.83% past 1 Year

Corporate filings & documents

Announcements

Letters sent to shareholders as per Reg 36
3 weeks ago
Letters sent to shareholders as per Reg 36
3 weeks ago
Newspaper Publication for 41st Notice of AGM.
3 weeks ago
Newspaper Publication for 41st Notice of AGM.
3 weeks ago
ANNUAL REPORT FOR FY 2025-26
3 weeks ago
ANNUAL REPORT FOR FY 2025-26
3 weeks ago
Notice of 41st AGM to be held on 29.09.2026
3 weeks ago
Notice of 41st AGM to be held on 29.09.2026
3 weeks ago
Publication of Un-audited financial results for the quarter ended June 30 2026.
1 month ago
Publication of Un-audited financial results for the quarter ended June 30 2026.
1 month ago
Outcome of Board Meeting held on August 13 2026 to consider and approve inter-alia un-audited financial results of the company for quarter ended June 30 2026.
1 month ago
Outcome of Board Meeting held on August 13 2026 to consider and approve inter-alia un-audited financial results of the company for quarter ended June 30 2026.
1 month ago
Outcome of Board Meeting held on August 13 2026 to consider and approve inter-alia un-audited financial results of the company for quarter ended June 30 2026.
1 month ago
Outcome of Board Meeting held on August 13 2026 to consider and approve inter-alia un-audited financial results of the company for quarter ended June 30 2026.
1 month ago
Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Un-Audited Financial Results Of The Company For The Quarter Ended June 30 2026.
1 month ago
Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Un-Audited Financial Results Of The Company For The Quarter Ended June 30 2026.
1 month ago
Certificate under Reg 74(5)
2 months ago
Certificate under Reg 74(5)
2 months ago
Closure of Trading Window for the quarter ended June 30 2026.
3 months ago
Closure of Trading Window for the quarter ended June 30 2026.
3 months ago
Newspaper publication of Audited Financial Results for Quarter and Year ended 31.03.2026
3 months ago
Newspaper publication of Audited Financial Results for Quarter and Year ended 31.03.2026
3 months ago
Intimation regarding non-applicability of Regulation 23(9)
3 months ago
Intimation regarding non-applicability of Regulation 23(9)
3 months ago
BSE Intimation for Non-Applicability of Annual Secretarial Compliance Report under Regulation 24A
3 months ago
BSE Intimation for Non-Applicability of Annual Secretarial Compliance Report under Regulation 24A
3 months ago
The Board of Directors today in their meeting considered and approved the audited financial results for quarter and year ended 31st March 2026
3 months ago
The Board of Directors today in their meeting considered and approved the audited financial results for quarter and year ended 31st March 2026
3 months ago
Outcome of the Board Meeting of the Company held on 29th May 2026 and submissions of Audited Financial Results for the Quarter and year ended 31.03.2026
3 months ago
Outcome of the Board Meeting of the Company held on 29th May 2026 and submissions of Audited Financial Results for the Quarter and year ended 31.03.2026
3 months ago
Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the audited financial results of the Company for the quarter and financial year ended March 31 2026.
4 months ago
Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the audited financial results of the Company for the quarter and financial year ended March 31 2026.
4 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Brawn Biotech Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L74899DL1985PLC022468</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: PRIYANKA SHARMA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: RATI GARG <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 13/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months ago
Certificate under Reg 74(5) of SEBI (DP) Regulations 2018
5 months ago
Closure of Trading Window from 01st April 2026 till 48 hours after the declaration of financial results for the quarter and financial year ended 31st March 2026.
5 months ago
Closure of Trading Window from 01st April 2026 till 48 hours after the declaration of financial results for the quarter and financial year ended 31st March 2026.
5 months ago
Appointment of Internal Auditors and Secretarial Auditor for FY 2025-26.
6 months ago
Newspaper Advertisement for special window for transfer of physical shares.
6 months ago
Newspaper publication of Unaudited Financial Results for Quarter and year to date ended 31.12.2025.
7 months ago
OUTCOME OF BOARD MEETING HELD ON TODAY
7 months ago
Unaudited Financial Results for quarter and nine months ended 31.12.2025
7 months ago
Unaudited Financial Results for quarter and nine months ended 31.12.2025
7 months ago
Prior Intimation for Board Meeting scheduled to be held on 14th February 2026 to consider and approve unaudited financial results for the quarter ended 31st December 2025.
7 months ago
Appointment of Chief Financial Officer.
7 months ago
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
8 months ago
Resignation of Ms. Pooja Pandey (CFO and KMP).
8 months ago
General Announcement
8 months ago
INTIMATION REGARDING CLOSURE OF TRADING WINDOW
9 months ago
ADDITIONAL DETAILS REQUIRED FOR CORPORATE ANNOUNCEMENT UNDER REGULATION 30
9 months ago
Disclosure under regulation 30 of the SEBI (LODR) Regulations for resigantion of Director
10 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Brawn Biotech Ltd Share Price Today

The Brawn Biotech Ltd share price today is ₹23.80. During the trading session, the Brawn Biotech Ltd share price opened at ₹23.80 and recorded an intraday high of ₹23.80 and a low of ₹23.80. Last closing price was ₹22.70. Over the past 52 weeks, the Brawn Biotech Ltd share price has ranged between ₹17.71 and ₹24.37. The current Brawn Biotech Ltd stock price reflects real-time market activity based on executed trades on the exchange.